Back

Empagliflozin's role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Metabolic syndrome and heart disease (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Cristiane Lauretti

University of Sao Paulo, Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail
HFpEF and glycemic variability: GHIDD Trial
Professor G. Fazio (Palermo, IT)
Abstract Slides Video
Presentation thumbnail
Telomere length across spectrum of metabolic health.
Associate Professor T. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Spermidine attenuates left ventricular dysfunction in estrogen deprived aging rats through mitigating lipid peroxidation and mitochondrial dysfunction
Doctor C. Maneechote (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Elevated levels of plasma inactive stromal cell derived factor-1a predict long-term adverse outcomes in diabetic patients with coronary artery disease
Assistant Professor Y. Chikata (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic syndrome and heart disease (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Synthetic HRV assessment of autonomic modulation effects induced by empaglifozin added to optimized therapy in a patient with post-COVID paroxysmal atrial fibrillation-induced heart failure and normal
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists improve indices of atrial cardiomyopathy: a systematic review and meta-analysis
thumbnail
Congress Presentation
Impact of dapagliflozin on supraventricular and ventricular arrhythmias, assessed by Holter ECG, in patients with heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources